MYC and adrenal cortex carcinoma: Consistent with Ferrarotto et al.’s report (2022) [6], the gene expression analysis of ACC revealed identified potential therapeutic targets including G2-M checkpoint genes, E2F, MYC targets, IFN, MTORC1, RAS signalling and the FGF/IGF/PI3K and NOTCH pathways [62].